PRECIPIO, INC. Stock Split Ratio
PRECIPIO, INC. (PRPO) had Stock Split Ratio of 5.00% as of 2023-09-21, per its 10-K filed 2025-03-27.
Financial Statements › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-03-27
- PRECIPIO, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2018 was 3.30%, a 0.00% change from fiscal 2017.
- PRECIPIO, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2017 was 3.30%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|
| 2023-09-21 | 5.00% 10-K · filed 2025-03-27 | ||
| 2019-04-25 | 1500.00% 10-Q · filed 2019-08-09 | ||
| 2018-12-31 | 3.30% 10-K · filed 2019-04-16 | ||
| 2017-12-31 | 3.30% 10-K · filed 2018-04-13 | ||
| 2014-01-27 | 8.33% 10-K · filed 2016-04-14 | 8.33% 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |